Search research articles
Contact Us
Filters
Showing results (341-350 of 504) with videos related to
Page
of 51
Sort By:
Molecular Imaging
|
January 6, 2022
The Number of Frames on ECG-Gated <sup>18</sup>F-FDG Small Animal PET Has a Significant Impact on LV Systolic and Diastolic Functional Parameters
Christoph Eissler, Rudolf A Werner, Paula Arias-Loza, et al.
Clinical Genitourinary Cancer
|
October 19, 2016
Correlation of PSMA-Targeted <sup>18</sup>F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer
Jeffrey J Tosoian, Michael A Gorin, Steven P Rowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2017
Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
Matthias Eiber, Wolfgang P Fendler, Steven P Rowe, et al.
Frontiers in Oncology
|
September 3, 2019
CXCR4-Directed Imaging in Solid Tumors
Rudolf A Werner, Stefan Kircher, Takahiro Higuchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 14, 2017
Low-Level Endogenous PSMA Expression in Nonprostatic Tumor Xenografts Is Sufficient for In Vivo Tumor Targeting and Imaging
Sridhar Nimmagadda, Mrudula Pullambhatla, Ying Chen, et al.
Radiology
|
December 9, 2025
Navigating the Scoring Systems and Interpretation Frameworks of Prostate-specific Membrane Antigen PET
Sungmin Woo, Benedetta Masci, Steven P Rowe, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 1, 2022
Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA I&T during long-term follow-up
Philipp E Hartrampf, Anna Katharina Seitz, Franz-Xaver Weinzierl, et al.
Annals of Nuclear Medicine
|
August 20, 2015
Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted ¹⁸F-DCFPyL PET/CT
Steven P Rowe, Michael A Gorin, Hans J Hammers, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 25, 2021
<sup>64</sup>Cu-PSMA-BCH: a new radiotracer for delayed PET imaging of prostate cancer
Teli Liu, Chen Liu, Zhongyi Zhang, et al.
Clinical Nuclear Medicine
|
April 19, 2022
Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and Therapy
Sebastian E Serfling, Philipp E Hartrampf, Yingjun Zhi, et al.
Page
of 51
Search research articles
Search
Showing results (341-350 of 504) with videos related to
Sort By:
Page
of 51
Molecular Imaging
|
January 6, 2022
The Number of Frames on ECG-Gated <sup>18</sup>F-FDG Small Animal PET Has a Significant Impact on LV Systolic and Diastolic Functional Parameters
Christoph Eissler, Rudolf A Werner, Paula Arias-Loza, et al.
Clinical Genitourinary Cancer
|
October 19, 2016
Correlation of PSMA-Targeted <sup>18</sup>F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer
Jeffrey J Tosoian, Michael A Gorin, Steven P Rowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2017
Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
Matthias Eiber, Wolfgang P Fendler, Steven P Rowe, et al.
Frontiers in Oncology
|
September 3, 2019
CXCR4-Directed Imaging in Solid Tumors
Rudolf A Werner, Stefan Kircher, Takahiro Higuchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 14, 2017
Low-Level Endogenous PSMA Expression in Nonprostatic Tumor Xenografts Is Sufficient for In Vivo Tumor Targeting and Imaging
Sridhar Nimmagadda, Mrudula Pullambhatla, Ying Chen, et al.
Radiology
|
December 9, 2025
Navigating the Scoring Systems and Interpretation Frameworks of Prostate-specific Membrane Antigen PET
Sungmin Woo, Benedetta Masci, Steven P Rowe, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 1, 2022
Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA I&T during long-term follow-up
Philipp E Hartrampf, Anna Katharina Seitz, Franz-Xaver Weinzierl, et al.
Annals of Nuclear Medicine
|
August 20, 2015
Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted ¹⁸F-DCFPyL PET/CT
Steven P Rowe, Michael A Gorin, Hans J Hammers, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 25, 2021
<sup>64</sup>Cu-PSMA-BCH: a new radiotracer for delayed PET imaging of prostate cancer
Teli Liu, Chen Liu, Zhongyi Zhang, et al.
Clinical Nuclear Medicine
|
April 19, 2022
Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and Therapy
Sebastian E Serfling, Philipp E Hartrampf, Yingjun Zhi, et al.
Page
of 51